Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy
Clinical trial NCT04115839 · TERMINATED
Trial details
- NCT number
- NCT04115839
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-13
- Primary completion
- 2021-01-04
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.